HIV Vpr, CRL4.DCAF1 E3 ligase and their targets
HIV Vpr、CRL4.DCAF1 E3 连接酶及其靶标
基本信息
- 批准号:9419040
- 负责人:
- 金额:$ 45.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBasic ScienceBindingBinding ProteinsBiological AssayCD4 Positive T LymphocytesCell LineCellsClustered Regularly Interspaced Short Palindromic RepeatsComplementary DNAComplexDNA BindingDNA DamageDNA Repair GeneDNA analysisEXO1 geneEnzymesEventGTPase-Activating ProteinsGenesHIVHIV-1ImmunityInfectionLeadLengthLife Cycle StagesLigaseLinkMediatingModelingMolecularMutationPathway interactionsProcessProtein BiosynthesisProteinsProvirus IntegrationProvirusesRNA InterferenceReportingReverse TranscriptionSMARCA3 geneStructureSurgical FlapsSystemT-LymphocyteTestingTranscriptTranscription ProcessUncertaintyViralVirulence FactorsVirusbasecofactorexperimental studyhelicaseinsightmulticatalytic endopeptidase complexnovelnucleaseprotein complexprotein structurerepair enzymerepairedscaffoldubiquitin-protein ligaseuracil-DNA glycosylasevpr Gene Products
项目摘要
PROJECT SUMMARY
Intrinsic immunity to HIV is counteracted by accessory virulence factors, which, typically, reprogram E3 Ub
ligases to remove HIV restriction factors from infected cells by targeting them for degradation by proteasome.
Indeed, the studies of HIV accessory proteins have led to the identification of major HIV restriction factors,
which in turn revealed new anti-viral mechanisms. HIV-1 Vpr accessory protein binds to CRL4DCAF1 E3 ubiquitin
ligase and uses this enzyme to antagonize specific postreplication DNA repair proteins, such as uracil DNA
glycosylase (UNG2), HLTF DNA helicase and MUS81 structure specific nuclease. Furthermore, we recently
identified Exonuclease 1 (Exo1) DNA repair protein as a novel target of the hijacked by Vpr CRL4DCAF1 E3.
HIV-1 Vpr was also reported to bind DNA processing proteins, which associate with a large protein complex
assembled on SLX4 scaffold that connects to diverse DNA repair pathways. The fact that Vpr interacts with
and disrupts multiple aspects of the cellular DNA repair machinery is intriguing, as there is little doubt that Vpr
antagonism with this machinery should ultimately benefit HIV-1. Nevertheless, very little is known about how
the DNA repair proteins targeted by Vpr impinge on HIV-1 replication and the underlying mechanism(s) have
not been thoroughly investigated.
This application focuses on how DNA repair proteins antagonized by Vpr and those controlled by the
SLX4 scaffold impinge on HIV-1 replication. We recently confirmed that HIV-1 Vpr promotes HIV-1 replication
in dividing T cells and linked this effect to Vpr's ability to antagonize DNA repair proteins via CRL4DCAF1 E3. We
also demonstrated that an as yet unidentified component controlled by the SLX4 scaffold inhibits HIV-1
infection. We hypothesize that the above DNA repair proteins act on intermediates in the synthesis of the
double stranded HIV-1 cDNA prior to, or following provirus integration, thereby inhibiting HIV-1 infection, and
that some of these effects are counteracted by HIV-1 Vpr. Here we propose to characterize the interactions
between DNA repair proteins targeted by Vpr, as well as those controlled by the SLX4 scaffold, with the HIV-1
cDNA and elucidate how they inhibit HIV-1 replication. In particular, we will characterize the actions of DNA
repair proteins that are antagonized by Vpr to stimulate HIV-1 replication (SA1), identify steps that the SLX4
complex and Vpr-CRL4DCAF1 E3-targeted HLTF and Exo1 act on (SA2), and characterize DNA repair pathways
and activities that inhibit HIV-1 (SA3). Overall, this application will describe the molecular mechanisms
mediating the inhibition of HIV-1 replication in dividing T lymphocytes by cellular DNA repair machinery, and
those used by HIV-1 Vpr to antagonize the inhibition.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacek Skowronski其他文献
Jacek Skowronski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacek Skowronski', 18)}}的其他基金
Restriction of HIV infection by SAMHD1 protein
SAMHD1蛋白限制HIV感染
- 批准号:
8409956 - 财政年份:2012
- 资助金额:
$ 45.84万 - 项目类别:
Restriction of HIV infection by SAMHD1 protein
SAMHD1蛋白限制HIV感染
- 批准号:
9087139 - 财政年份:2012
- 资助金额:
$ 45.84万 - 项目类别:
Restriction of HIV infection by SAMHD1 protein
SAMHD1蛋白限制HIV感染
- 批准号:
8865542 - 财政年份:2012
- 资助金额:
$ 45.84万 - 项目类别:
Restriction of HIV infection by SAMHD1 protein
SAMHD1蛋白限制HIV感染
- 批准号:
8463991 - 财政年份:2012
- 资助金额:
$ 45.84万 - 项目类别:
MOLECULAR BIOLOGY OF LENTIVIRAL VPR AND VPX PROTEINS
慢病毒 VPR 和 VPX 蛋白的分子生物学
- 批准号:
7994402 - 财政年份:2008
- 资助金额:
$ 45.84万 - 项目类别:
相似海外基金
HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
- 批准号:
2318404 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
- 批准号:
10552484 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
- 批准号:
10576701 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
- 批准号:
480914 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 45.84万 - 项目类别:
Australian Laureate Fellowships
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
- 批准号:
22K02974 - 财政年份:2022
- 资助金额:
$ 45.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
- 批准号:
10517004 - 财政年份:2022
- 资助金额:
$ 45.84万 - 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
- 批准号:
10431468 - 财政年份:2022
- 资助金额:
$ 45.84万 - 项目类别:














{{item.name}}会员




